DNA Chip Research Inc. (TYO:2397)
1,090.00
0.00 (0.00%)
May 2, 2025, 3:30 PM JST
DNA Chip Research Revenue
DNA Chip Research had revenue of 303.00M JPY in the quarter ending December 31, 2024, with 183.18% growth. This brings the company's revenue in the last twelve months to 962.00M, up 123.20% year-over-year. In the fiscal year ending March 31, 2024, DNA Chip Research had annual revenue of 490.00M with 49.85% growth.
Revenue (ttm)
962.00M
Revenue Growth
+123.20%
P/S Ratio
7.67
Revenue / Employee
26.00M
Employees
37
Market Cap
7.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 490.00M | 163.00M | 49.85% |
Mar 31, 2023 | 327.00M | -100.00M | -23.42% |
Mar 31, 2022 | 427.00M | 103.00M | 31.79% |
Mar 31, 2021 | 324.00M | -37.00M | -10.25% |
Mar 31, 2020 | 361.00M | 1.00M | 0.28% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Daiichi Sankyo Company | 1,886.26B |
Takeda Pharmaceutical Company | 4,579.02B |
HOYA Corporation | 838.60B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,912.32B |
Olympus | 993.33B |